Document is current
Any future updates will be listed below
-
Authors
Otsuka, Yasuhiro
Ishii, Masanobu
Tabata, Noriaki
Oda, Seitaro
Kidoh, Masafumi
Shirahama, Yuichiro
Egashira, Koichi
Kuyama, Naoto
Rokutanda, Taku
Noda, Katsuo
Horio, Eiji
Sakamoto, Tomohiro
Kudo, Takashi
Shimomura, Hideki
Ikemoto, Tomokazu
Tsunoda, Ryusuke
Nakamura, Taishi
Matsui, Kunihiko
Kaikita, Koichi
Tsujita, Kenichi
,
-
Funding
Funding for this research was provided by:
Daiichi Sankyo Co., Ltd
- License Information
-
More Information
Article History
Received: 29 February 2024
Accepted: 21 June 2024
First Online: 28 June 2024
Competing interests
: Dr. Kaikita reports remuneration for lectures from Bayer Yakuhin, Ltd., Daiichi Sankyo Co., Ltd., Novartis Pharma AG, and Otsuka Pharmaceutical Co., Ltd.; has received trust research/joint research funds from Bayer Yakuhin, Ltd., and Daiichi Sankyo Co., Ltd.; and has received scholarship funds from Abbott Medical Co., Ltd.. Dr. Tsujita received significant research grant from AMI Co., Ltd., Bayer Yakuhin, Ltd., Bristol-Myers K.K., EA Pharma Co. Ltd., Mochida Pharmaceutical Co., Ltd., and scholarship fund from AMI Co., Ltd., Bayer Yakuhin, Ltd., Boehringer Ingelheim Japan, Chugai Pharmaceutical Co, Ltd., Daiichi Sankyo Co., Ltd., Edwards Lifesciences Corporation, Johnson & Johnson K.K., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and honoraria from Amgen K.K., Bayer Yakuhin, Ltd., Daiichi Sankyo Co., Ltd., Kowa Pharmaceutical Co. Ltd., Novartis Pharma K.K., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., and belongs to the endowed departments donated by Abbott Japan Co., Ltd., Boston Scientific Japan K.K., Fides-one, Inc., GM Medical Co., Ltd., ITI Co., Ltd., Kaneka Medix Co., Ltd., NIPRO CORPORATION, TERUMO Co, Ltd., Abbott Medical Co., Ltd., Cardinal Heaith Japan, Fukuda Denshi Co., Ltd., Japan Lifeline Co., Ltd., Medical Appliance Co., Ltd., Medtoronic Japan Co., Ltd. The remaining authors have nothing to disclose.
